id,pmid,year,seq,MAP,name,cter,nter,lyn_cyc,ldmix,non_nat,len,nature,activity,source,origin,exp_str,non_hem,dssp,smiles
1643,16137634,2005,RQIKIWFQNRRMKWKK,RQIKIWFQNRRMKWKK{ct:Amid},pAntp(43–58),Amidation,Free,Linear,L,None,16,CPP,20.0±1.8% Hemolysis at 50 µM,Bovine,Penetratin (fragment of Antennapedia homeodomain),NA,NA,CCCCCCCCCCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
1644,16137634,2005,GRKKRRQRRRPPQ,GRKKRRQRRRPPQ{ct:Amid},pTAT(48–60),Amidation,Free,Linear,L,None,13,CPP,11.2±1.5% Hemolysis at 50 µM,Bovine,Fragment of transcription factor coded by theTat protein (HIV virus),NA,NA,CCTTSCCSSCCCC,N=C(N)NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O
1645,16137634,2005,LLIILRRRIRKQAHAHSK,LLIILRRRIRKQAHAHSK{ct:Amid},pVEC(615–632),Amidation,Free,Linear,L,None,18,CPP,18.1±0.3% Hemolysis at 50 µM,Bovine,Vascular endothelial cadherin protein (Murine),NA,NA,CTTTCGGGHHHHCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O
1646,16137634,2005,KLALKLALKALKAALKLA,KLALKLALKALKAALKLA{ct:Amid},MAP,Amidation,Free,Linear,L,None,18,CPP,20.9±1.8% Hemolysis at 50 µM,Bovine,Synthetic peptide,NA,NA,CGGGTTTHHHHHHHGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
1647,16137634,2005,AGYLLGKINLKALAALAKKIL,AGYLLGKINLKALAALAKKIL{ct:Amid},Transportan 10,Amidation,Free,Linear,L,None,21,CPP,29.0±4.9% Hemolysis at 50 µM,Bovine,Galanin and Mastoparan fragments,NA,NA,CCSCCCSSCHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
2700,22328546,2012,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,CPP,>80% hemolytic at 25 µM at pH 8,Human,Melittin (Apis mellifera),NA,NA,CCCSSHHHHHHSCHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
2701,22328546,2012,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,CPP,<60% hemolytic at 25 µM at pH 6,Human,Melittin (Apis mellifera),NA,NA,CCCSSHHHHHHSCHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
2702,22328546,2012,GIGAVLKVLTTGLPALISWI,GIGAVLKVLTTGLPALISWI,MT20,Free,Free,Linear,L,None,20,CPP,<80% hemolytic at 25 µM at pH 8,Human,Truncated peptides of melittin,NA,NA,CCSBGGGCSSCCCSSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(=O)O
2703,22328546,2012,GIGAVLKVLTTGLPALISWI,GIGAVLKVLTTGLPALISWI,MT20,Free,Free,Linear,L,None,20,CPP,40% hemolytic at 25 µM at pH 5,Human,Truncated peptides of melittin,NA,NA,CCSBGGGCSSCCCSSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(=O)O
2704,22328546,2012,GIGAILKVLATGLPTLISWIKNKRKQ,GIGAILKVLATGLPTLISWIKNKRKQ,Florae,Free,Free,Linear,L,None,26,CPP,<70% hemolytic at 25 µM at pH 6,Human,Melittin analog,NA,NA,CCTTSHHHHTTTSHHHHHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)CC
2705,22328546,2012,GIGAILKVLATGLPTLISWIKNKRKQ,GIGAILKVLATGLPTLISWIKNKRKQ,Florae,Free,Free,Linear,L,None,26,CPP,~80% hemolytic at 25 µM at pH 8,Human,Melittin analog,NA,NA,CCTTSHHHHTTTSHHHHHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)CC
2706,22328546,2012,GIGAILKVLATGLPTLISWI,GIGAILKVLATGLPTLISWI,FL20,Free,Free,Linear,L,None,20,CPP,<60% hemolytic at 25 µM at pH 5,Human,Truncated peptides of florae (Apis florae),NA,NA,CCTHHHHGGGSCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(=O)O
2707,22328546,2012,GIGAILKVLATGLPTLISWI,GIGAILKVLATGLPTLISWI,FL20,Free,Free,Linear,L,None,20,CPP,~80% hemolytic at 25 µM at pH 8,Human,Truncated peptides of florae (Apis florae),NA,NA,CCTHHHHGGGSCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(=O)O
2968,21956793,2011,LLIILRRRIRKQAHAHSK,LLIILRRRIRKQAHAHSK{ct:Amid},pVEC,Amidation,Free,Linear,L,None,18,Antimicrobial and CPP,>10% hemolytic at 200 µM,Human,Vascular endothelial-cadherin protein derivative analog (Murine),NA,NA,CTTTCGGGHHHHCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O
2969,21956793,2011,LLIILRRRWRKQARARSK,LLIILRRRWRKQARARSK{ct:Amid},pVEC-a1,Amidation,Free,Linear,L,None,18,Antimicrobial and CPP,>10% hemolytic at 200 µM,Human,Vascular endothelial-cadherin protein derivative analog (Murine),NA,NA,CGGGCGGGHHHHTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
2970,21956793,2011,LLIILRRRWRKQAKAKSK,LLIILRRRWRKQAKAKSK{ct:Amid},pVEC-a2,Amidation,Free,Linear,L,None,18,Antimicrobial and CPP,>10% hemolytic at 200 µM,Human,Vascular endothelial-cadherin protein derivative analog (Murine),NA,NA,CGGGCGGGHHHHGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
2971,21956793,2011,LLIILRRRWRRQARARSR,LLIILRRRWRRQARARSR{ct:Amid},pVEC-a3,Amidation,Free,Linear,L,None,18,Antimicrobial and CPP,>10% hemolytic at 94 µM,Human,Vascular endothelial-cadherin protein derivative analog (Murine),NA,NA,CCCCCHHHHTTTGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
2972,21956793,2011,LLIILKKKWKKQAKAKSK,LLIILKKKWKKQAKAKSK{ct:Amid},pVEC-a4,Amidation,Free,Linear,L,None,18,Antimicrobial and CPP,>10% hemolytic at 200 µM,Human,Vascular endothelial-cadherin protein derivative analog (Murine),NA,NA,CCSCCGGGHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
3168,22965637,2013,ILGKLLSTAAGLLSNL,ILGKLLSTAAGLLSNL{ct:Amid},Alyteserin-2a,Amidation,Free,Linear,L,None,16,CPP,LC50 = 140 µM,Human,Derived from skin secretions of Alytes obstetricans (alyteserin-2a),α-helical,NA,CCSCGGGTCGGGTSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3169,22965637,2013,ILKKLLSTAAGLLSNL,ILKKLLSTAAGLLSNL{ct:Amid},G3K,Amidation,Free,Linear,L,None,16,CPP,LC50 = 105 µM,Human,Alyteserin-2a analog,NA,NA,CHHHHHHHHHTTCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3170,22965637,2013,ILGKLLKTAAGLLSNL,ILGKLLKTAAGLLSNL{ct:Amid},S7K,Amidation,Free,Linear,L,None,16,CPP,LC50 = 28 µM,Human,Alyteserin-2a analog,NA,NA,CHHHHHTTTTTTCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3171,22965637,2013,ILGKLLkTAAGLLSNL,ILGKLLK{d}TAAGLLSNL{ct:Amid},S7k,Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 105 µM,Human,Alyteserin-2a analog,NA,NA,CHHHHHTTTTTTCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3172,22965637,2013,ILGKLLSTAAKLLSNL,ILGKLLSTAAKLLSNL{ct:Amid},G11K,Amidation,Free,Linear,L,None,16,CPP,LC50 = 24 µM,Human,Alyteserin-2a analog,NA,NA,CHHHHHHHHHHHHSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3173,22965637,2013,ILGKLLSTAAkLLSNL,ILGKLLSTAAK{d}LLSNL{ct:Amid},G11k,Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 42 µM,Human,Alyteserin-2a analog,NA,NA,CHHHHHHHHHHHHSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3174,22965637,2013,ILGKLLSTAAGLLKNL,ILGKLLSTAAGLLKNL{ct:Amid},S14K,Amidation,Free,Linear,L,None,16,CPP,LC50 = 55 µM,Human,Alyteserin-2a analog,NA,NA,CCCCTHHHHHHHHTCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3175,22965637,2013,ILGKLLSTAAGLLSKL,ILGKLLSTAAGLLSKL{ct:Amid},N15K,Amidation,Free,Linear,L,None,16,CPP,LC50 = 50 µM,Human,Alyteserin-2a analog,NA,NA,CCCSGGGGTEETTEEC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3176,22965637,2013,ILGKLLSTAAGLLSkL,ILGKLLSTAAGLLSK{d}L{ct:Amid},N15k,Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 310 µM,Human,Alyteserin-2a analog,NA,NA,CCCSGGGGTEETTEEC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3177,22965637,2013,ILGKLLKTAAKLLSNL,ILGKLLKTAAKLLSNL{ct:Amid},"S7K,G11K",Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 38 µM,Human,Alyteserin-2a analog,NA,NA,CHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3178,22965637,2013,ILGKLLkTAAkLLSNL,ILGKLLK{d}TAAK{d}LLSNL{ct:Amid},"S7k,G11k",Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 185 µM,Human,Alyteserin-2a analog,NA,NA,CHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3179,22965637,2013,ILGKLLSTAAKLLSKL,ILGKLLSTAAKLLSKL{ct:Amid},"G11K,N15K",Amidation,Free,Linear,L,None,16,CPP,LC50 = 16 µM,Human,Alyteserin-2a analog,NA,NA,CGGGGGHHHHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3180,22965637,2013,ILGKLLSTAAkLLSKL,ILGKLLSTAAK{d}LLSKL{ct:Amid},"G11k,N15K",Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 195 µM,Human,Alyteserin-2a analog,NA,NA,CGGGGGHHHHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3181,22965637,2013,ILGKLLSWAAGLLSNL,ILGKLLSWAAGLLSNL{ct:Amid},T8W,Amidation,Free,Linear,L,None,16,CPP,LC50 = 13 µM,Human,Alyteserin-2a analog,NA,NA,CTTSGGGGGGGTCSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O
3182,22965637,2013,ILGKLLSTWAGLLSNL,ILGKLLSTWAGLLSNL{ct:Amid},A9W,Amidation,Free,Linear,L,None,16,CPP,LC50 = 39 µM,Human,Alyteserin-2a analog,NA,NA,CCCCGGGGGTTTTSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3183,22965637,2013,ILGKLLSTAWGLLSNL,ILGKLLSTAWGLLSNL{ct:Amid},A10W,Amidation,Free,Linear,L,None,16,CPP,LC50 = 11 µM,Human,Alyteserin-2a analog,NA,NA,CHHHHHTTGGGTSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3184,22965637,2013,ILGKLLSTAWkLLSNL,ILGKLLSTAWK{d}LLSNL{ct:Amid},"A10W,G11k",Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 21 µM,Human,Alyteserin-2a analog,NA,NA,CTTHHHHHHHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3185,22965637,2013,ILGKLLSTAWGLLSKL,ILGKLLSTAWGLLSKL{ct:Amid},"A10W,N15K",Amidation,Free,Linear,L,None,16,CPP,LC50 = 6 µM,Human,Alyteserin-2a analog,NA,NA,CCSCTHHHHTTTSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3186,22965637,2013,ILGKLLSTAWALLSkL,ILGKLLSTAWALLSK{d}L{ct:Amid},"A10W,N15k",Amidation,Free,Linear,Mix,None,16,CPP,LC50 = 27 µM,Human,Alyteserin-2a analog,NA,NA,CTTHHHHHHHHHHTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
3274,23776609,2013,RAGLQFPVGRLLR,RAGLQFPVGRLLR,BR1,Free,Free,Linear,L,None,13,CPP,Inactive,Human,buforin IIb,NA,Non-hemolytic,CCSCCCCCSSCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
3275,23776609,2013,RAGLQFPVGRLLRRLLR,RAGLQFPVGRLLRRLLR,BR2,Free,Free,Linear,L,None,17,CPP,Inactive,Human,buforin IIb,NA,Non-hemolytic,CCCCCCCTHHHHHHHHC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
3276,23776609,2013,RAGLQFPVGRLLRRLLRRLLR,RAGLQFPVGRLLRRLLRRLLR,BR3,Free,Free,Linear,L,None,21,CPP,5% Hemolysis at 25 µM,Human,buforin IIb,NA,NA,CCSSCCCHHHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
3277,23776609,2013,RAGLQFPVGRLLRRLLRRLLR,RAGLQFPVGRLLRRLLRRLLR,BR3,Free,Free,Linear,L,None,21,CPP,34.3% Hemolysis at 200 µM,Human,buforin IIb,NA,NA,CCSSCCCHHHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
3278,23776609,2013,RKKRRQRRR,RKKRRQRRR,Tat (49–57),Free,Free,Linear,L,None,9,CPP,Inactive,Human,buforin IIb,NA,Non-hemolytic,CGGGTSCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
9139,29411917,2018,aza-β3Lys-K-aza-β3-1Nal-K-aza-β3-1Nal-L,{nnr:aza-β3Lys}-K-{nnr:aza-β3-1Nal}-K-{nnr:aza-β3-1Nal}-L{cyc:N-C},ACPP20,Free,Free,Cyclic,L,"aza-β3-Lys = aza-β3-Lysine, aza-β3-1Nal = aza-β3-1-Naphthylalanine",6,Antimicrobial cyclic pseudopeptides (ACPPs),1.5 % Hemolysis at 100 µM,Sheep,Synthesis Of Mixed Aza-Β3-Pseudopeptides,NA,Low hemolytic,NA,NA
9140,29411917,2018,aza-β3Lys-K-aza-β3-2Nal-L-aza-β3-2Nal-L,{nnr:aza-β3Lys}-K-{nnr:aza-β3-2Nal}-L-{nnr:aza-β3-2Nal}-L{cyc:N-C},ACPP21,Free,Free,Cyclic,L,"aza-β3-Lys = aza-β3-Lysine, aza-β3-2Nal = aza-β3-2-Naphthylalanine",6,Antimicrobial cyclic pseudopeptides (ACPPs),8 % Hemolysis at 100 µM,Sheep,Synthesis Of Mixed Aza-Β3-Pseudopeptides,NA,NA,NA,NA
9141,29411917,2018,aza-β3Lys-K-aza-β3-1Nal-L-aza-β3-4Fluo-1Nal-L,{nnr:aza-β3Lys}-K-{nnr:aza-β3-1Nal}-L-{nnr:aza-β3-4Fluo-1Nal}-L{cyc:N-C},ACPP22,Free,Free,Cyclic,L,"aza-β3-Leu = aza-β3-Leucine, aza-β3-1Nal = aza-β3-1-Naphthylalanine, aza-β3-4Fluo-1Nal = aza-β3-4Fluoro-1-Nahphtylalanine",6,Antimicrobial cyclic pseudopeptides (ACPPs),5 % Hemolysis at 100 µM,Sheep,Synthesis Of Mixed Aza-Β3-Pseudopeptides,NA,Low hemolytic,NA,NA
9142,29411917,2018,K-aza-β3Lys-L-aza-β3-1Nal-aza-β3Leu-aza-β3-1Nal,K-{nnr:aza-β3Lys}-L-{nnr:aza-β3-1Nal}-aza-β3Leu-{nnr:aza-β3-1Nal}{cyc:N-C},ACPP23,Free,Free,Cyclic,L,"aza-β3-Lys = aza-β3-Lysine, aza-β3-1Nal = aza-β3-1-Naphthylalanine, aza-β3-Leu = aza-β3-Leucine, aza-β3-1Nal = aza-β3-1-Naphthylalanine",6,Antimicrobial cyclic pseudopeptides (ACPPs),6 % Hemolysis at 100 µM,Sheep,Synthesis Of Mixed Aza-Β3-Pseudopeptides,NA,NA,NA,NA
9143,29411917,2018,aza-β3Arg-R-aza-β3-1Nal-L-aza-β3-1Nal-L,aza-β3Arg-R-{nnr:aza-β3-1Nal}-L-{nnr:aza-β3-1Nal}-L{cyc:N-C},ACPP24,Free,Free,Cyclic,L,"aza-β3-Arg = aza-β3-Arginine, aza-β3-1Nal = aza-β3-1-Naphthylalanine",6,Antimicrobial cyclic pseudopeptides (ACPPs),12 % Hemolysis at 100 µM,Sheep,Synthesis Of Mixed Aza-Β3-Pseudopeptides,NA,NA,NA,NA
9144,29411917,2018,aza-β3Lys-R-aza-β3-2Nal-F-aza-β3-2Nal-F,{nnr:aza-β3Lys}-R-{nnr:aza-β3-2Nal}-F-{nnr:aza-β3-2Nal}-F{cyc:N-C},ACPP25,Free,Free,Cyclic,L,"aza-β3-Lys = aza-β3-Lysine, aza-β3-2Nal = aza-β3-2-Naphthylalanine",6,Antimicrobial cyclic pseudopeptides (ACPPs),50 % Hemolysis at 100 µM,Sheep,Synthesis Of Mixed Aza-Β3-Pseudopeptides,NA,NA,NA,NA
10940,32024261,2020,KARKKKLNKKGRKMAGRKRGRPKK,KARKKKLNKKGRKMAGRKRGRPKK,Dot1l,Free,Free,Linear,L,None,24,CPPs (Cell-penetrating peptides),<0.5 % Hemolysis at 10 µM,Human,Human Gene Dot1L,α-Helical,Non-hemolytic,CTHHHHHHHHHHHC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10941,32024261,2020,KARKKKLNKKGRKMAGRKRGRPKK,KARKKKLNKKGRKMAGRKRGRPKK,Dot1l,Free,Free,Linear,L,None,24,CPPs (Cell-penetrating peptides),<0.5 % Hemolysis at 7.5 µM,Human,Human Gene Dot1L,α-Helical,Non-hemolytic,CCHHHHHHHTTTCC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O